The role of Fas-FasL in the development and treatment of ischemic retinopathy

被引:39
作者
Barreiro, R
Schadlu, R
Herndon, J
Kaplan, HJ
Ferguson, TA
机构
[1] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA
[2] Univ Louisville, Dept Ophthalmol, Louisville, KY 40292 USA
关键词
D O I
10.1167/iovs.02-0478
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
PURPOSE. Define a role for Fas-FasL in oxygen-induced retinopathy and explore the mechanism of pigment-epithehum-derived growth factor (PEDF) inhibition in this model. METHODS. Seven-day-old mice C57BL/6J (B6), FasL-defective (B6-gld), or Fas-defective (B6-lpr) mice were exposed to 75% oxygen for 5 days (postnatal day [P]7-P12) and returned to room air. On day P17, vascular architecture was assessed microscopically after perfusion with FITC-dextran, and preretinal nuclei were quantified by PAS and hematoxylin staining. In some experiments, mice were treated intraperitoneally with PEDF. Vascular architecture and preretinal nuclei counts were compared with those in PBS-treated control animals. RESULTS. Oxygen-induced retinopathy was significantly increased in FasL-defective gld mice compared with wild-type B6 animals. This was manifested by an increase in the number of microaneurysms, neovascular tufts, and preretinal nuclei. PEDF treatment prevented retinopathy in B6, B6-gld, and B6-lpr mice. CONCLUSIONS. Fas-FasL interactions regulate the extent of oxygen-induced retinal neovascularization. The inhibition of neovascularization in B6 gld, and B6-lpr mice by PEDF suggests that Fas-FasL interactions are probably not the mechanism for inhibition in this model.
引用
收藏
页码:1282 / 1286
页数:5
相关论文
共 20 条
[1]   Enhanced and accelerated lymphoproliferation in Fas-null mice [J].
Adachi, M ;
Suematsu, S ;
Suda, T ;
Watanabe, D ;
Fukuyama, H ;
Ogasawara, J ;
Tanaka, T ;
Yoshida, N ;
Nagata, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (05) :2131-2136
[2]  
Booker JK, 1998, J IMMUNOL, V161, P4536
[3]  
DAMORE PA, 1994, INVEST OPHTH VIS SCI, V35, P3974
[4]   Pigment epithelium-derived factor: A potent inhibitor of angiogenesis [J].
Dawson, DW ;
Volpert, OV ;
Gillis, P ;
Crawford, SE ;
Xu, HJ ;
Benedict, W ;
Bouck, NP .
SCIENCE, 1999, 285 (5425) :245-248
[5]  
Duh EJ, 2002, INVEST OPHTH VIS SCI, V43, P821
[6]   Down-regulation of vascular endothelial growth factor and up-regulation of pigment epithelium-derived factor - A possible mechanism for the anti-angiogenic activity of plasminogen kringle 5 [J].
Gao, GQ ;
Li, Y ;
Gee, S ;
Dudley, A ;
Fant, J ;
Crosson, C ;
Ma, JX .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (11) :9492-9497
[7]   Unbalanced expression of VEGF and PEDF in ischemia-induced retinal neovascularization [J].
Gao, GQ ;
Li, Y ;
Zhang, DC ;
Gee, S ;
Crosson, C ;
Ma, JX .
FEBS LETTERS, 2001, 489 (2-3) :270-276
[8]   FAS LIGAND-INDUCED APOPTOSIS AS A MECHANISM OF IMMUNE PRIVILEGE [J].
GRIFFITH, TS ;
BRUNNER, T ;
FLETCHER, SM ;
GREEN, DR ;
FERGUSON, TA .
SCIENCE, 1995, 270 (5239) :1189-1192
[9]   The role of FasL-induced apoptosis in immune privilege [J].
Griffith, TS ;
Ferguson, TA .
IMMUNOLOGY TODAY, 1997, 18 (05) :240-244
[10]   The codependence of angiogenesis and chronic inflammation [J].
Jackson, JR ;
Seed, MP ;
Kircher, CH ;
Willoughby, DA ;
Winkler, JD .
FASEB JOURNAL, 1997, 11 (06) :457-465